Download PDF
Thromb Haemost 1964; 12(01): 201-210
DOI: 10.1055/s-0038-1655585
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Experimental Venous Thrombosis in Alloxan Diabetic Rats

Arne Nordöy   *
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway. (Head: H. Stormorken, M. D.)
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary and Conclusions

1. The effect of alloxan diabetes on thrombus formation has been examined in rats using a standardized damage of the jugular vein. No significant increase in the incidence of thrombosis as compared with the control group was observed.

2. An accelerated recalcification time, cephalin time and thromboplastin time was observed, as well as an increase in the levels of fibrinogen, factor VII and factor VIII.

3. The ADP-induced platelet adhesiveness in platelet rich plasma was decreased, possibly indicating a decrease in anti-Willebrand factor.

4. A slight increase in total cholesterol, free fatty acids and triglycerides in plasma was observed.

5. It is concluded from the present study that a thrombotic condition is not present in alloxan diabetic rats, although the activity of some coagulation factors is increased. The reason for this may be the decreased ADP-induced platelet adhesiveness in plasma.

* Research Fellow of the Norwegian Council on Cardiovascular Diseases.


 

  • References

  • 1 Albrink M. J, Lavietes P. H, Man E. B. Vascular disease and serum lipids in diabetes mellitus. Ann. intern. Med. 58: 305-323 1963;
    CrossrefPubMedGoogle Scholar
  • 2 Cagan R. N, Sobel A. E, Nichols R. A, Loewe L. Serum lipids in normal and alloxan diabetic rats. Metabolism 3: 168-172 1954;
    PubMedGoogle Scholar
  • 3 Duff C. L, McMillan C. C. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. J. exp. Med. 89: 611-630 1949;
    CrossrefPubMedGoogle Scholar
  • 4 Duguid J. B. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J. Path. Bact. 55: 207-212 1946;
    PubMedGoogle Scholar
  • 5 Egeberg O. Assay of antihemophilic A, B and C factors by one stage cephalin systems. Scand. J. clin. Lab. Invest. 13: 140-152 1961;
    CrossrefPubMedGoogle Scholar
  • 6 Egeberg O. Changes in the coagluation system following major surgical operations. Acta med. scand. 171: 679-685 1962;
    PubMedGoogle Scholar
  • 7 Egeberg O. Blood coagulability in diabetic patients. Scand. J. clin. Lab. Invest. 15: 533-538 1963; a
    CrossrefPubMedGoogle Scholar
  • 9 Egeberg O. Changes in the activity of antihemophilic A factor (factor VIII) and the bleeding time associated with muscular exercise and adrenalin infusion. Scand. J. clin. Lab. Invest. 15: 539-549 1963; b
    CrossrefPubMedGoogle Scholar
  • 10 Fiske C. H, Subbarow Y. The colometric determination of phosphorus. J. biol. Chem. 66: 375-400 1925;
    PubMedGoogle Scholar
  • 11 Hand R. A, Chandler A. B. Atherosclerotic metamorphosis of autologues pulmonary thromboemboli in the rabbit. Amer. J. Path. 40: 469-486 1962;
    PubMedGoogle Scholar
  • 12 Hasselback R, Hjort P. Effect of heparin on in vivo turnover of clotting factors. J. appi. Physiol. 15: 945-948 1960;
    PubMedGoogle Scholar
  • 13 Hange J. G, Nicolaysen R. A rapid and sensitive method for the determination of total serum cholesterol. Acta physiol. scand 43: 359-364 1958;
    CrossrefPubMedGoogle Scholar
  • 14 Hellem A. J. The adhesiveness of human blood platelets in vitro. Oslo University Press; Norway: 1960
    Google Scholar
  • 15 Hjort P, Rapaport S. I, Owren O. A. A simple, specific one-stage prothrombin assay using Russell’s viper venom in cephalin suspension. J. Lab. clin. Med. 46: 89-97 1955;
    PubMedGoogle Scholar
  • 16 Hultman E. Rapid specific method for determination of aldosaccharides in body fluids. Nature 183: 108-109 1959;
    CrossrefPubMedGoogle Scholar
  • 17 Hyvärinen A, Nikkila E. A. Specific determination of blood glucose with o-toluidine. Clin. chim. Acta 7: 140-143 1962;
    CrossrefPubMedGoogle Scholar
  • 18 Kalant N, Teitelbaum J. I, Cooperberg A. A, and Harland W. A. Dietary atherogenesis in alloxan diabetes. J. Lab. clin. Med. 63: 147-157 1964;
    PubMedGoogle Scholar
  • 19 Katz L. N, Stamler J. Experimental atherosclerosis. C. C. Thomas; Springfield, Ill., U. S. A.: 1953
    Google Scholar
  • 20 King E. J, Wooton I. D. P. Micro-Analysis. In: Medical Biochemistry. King E. J, and Wooton I. D.P. Editors J. & A. Churchill Ltd.; Third edition. 79 1959
    Google Scholar
  • 21 Lukens F. D. W. Alloxan diabetes. Physiol. Rev. 28: 304-330 1948;
    CrossrefPubMedGoogle Scholar
  • 22 McGill Jr. H. C, Holeman R. L. The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit. Proc. Soc. exp. Biol. 72: 72-75 1949;
    CrossrefPubMedGoogle Scholar
  • 23 Nordöy A. Experimental venous thrombosis in the rat. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 427-435 1963; a
    PubMedGoogle Scholar
  • 24 Nordöy A. Moderate intravascular hemolysis and experimental venous thrombosis in rats. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 214-222 1963; b
    PubMedGoogle Scholar
  • 25 Nordöy A, Ödegaard A. E. The influence of citrate and heparin on the adhesiveness of rat platelets and human platelets measured in vitro. Scand. J. clin. Lab. Invest. 15: 399-404 1963;
    CrossrefPubMedGoogle Scholar
  • 26 Nordöy A. Experimental venous thrombosis in rats, on high fat diets. In preparation (1964)
    PubMedGoogle Scholar
  • 27 Nicolaysen R, Nygaard A. P. The determination of triglycerides and phospholipids. Scand. J. clin. Lab. Invest. 15: 79-82 1963;
    CrossrefPubMedGoogle Scholar
  • 28 Owren P. A. The coagulation of blood. Investigation of a new clotting factor. Acta med. scand. 128. suppl. 194 1947
    PubMedGoogle Scholar
  • 29 Pierce Jr. F. T. Relationship of serum lipoproteins to atherosclerosis in cholesterol fed al-loxanized rabbit. Circulation 5: 401-407 1952;
    CrossrefPubMedGoogle Scholar
  • 30 Rokitansky C. A. Manual of pathological anatomy. Swaine E. W, & Sieveking E, Moore C. H, and Day G. E. (translators). Blanchard & Lea; Philadelphia: 1855. Vol. 4 198-207
    Google Scholar
  • 31 Schrade W, Boehle E, Biegler R, Hartmuth E. Fatty acid composition of lipid fractions in diabetic serum. Lancet 2: 285-290 1963;
    PubMedGoogle Scholar
  • 32 Spiro R. G, Hastings A. B. Studies on carbohydrate metabolism in rat liver slices. J. biol. Chem. 230: 751-759 1958;
    PubMedGoogle Scholar
  • 33 Stander J, Pick R, Katz L. N. Influences of thyroid, pancreatic and adrenal hormones on lipid metabolism and atherosclerosis in experimental animals. In: Hormones and Atherosclerosis. Ed. Pincus G. Acad. Press Inc. Pubi.; New York: 1959
    Google Scholar
  • 34 Sullivan J. F, Neu L. T, Goyle M. J. Serum lipids in diabetes and in coronary artery disease. Amer. J. med. Sci. 243: 11-116 1962;
    PubMedGoogle Scholar
  • 35 Thannhauser S. J. Serum lipids and their value in diagnosis. New Engl. J. Med. 237:515-522 and 237: 546-551 1947;
    PubMedGoogle Scholar
  • 36 Trout D. L, Harvey Estes Jr. E, Friedberg S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J. Lipid Res. 1: 199-202 1960;
    PubMedGoogle Scholar
  • 37 Ödegaard A. E, Hellem A. J, Skâlhegg B. A. Increased activity of “von Willebrand factor” in diabetic plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 11: 27 1964;
    PubMedGoogle Scholar
  • 38 Ödegaard A. E, Skâlhegg B. A, Hellem A. J. ADP induced platelet adhesiveness as a diagnostic test in von Willebrand’s disease. Thrombos. Diathes. haemorrh. (Stuttg.) 11: 23 1964;
    PubMedGoogle Scholar
  • 39 Aas K. Prokonvertin og konvertin. Thesis. Oslo Akad. Trykningssentral, Oslo, Norway (1952)
    PubMedGoogle Scholar